We are live on ! Find out more
ACIU icon

AC Immune
ACIU

39 hedge funds and large institutions have $191M invested in AC Immune in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

25% more capital invested

Capital invested by funds: $153M → $191M (+$38.2M)

22% more funds holding

Funds holding: 32 → 39 (+7)

1.65% more ownership

Funds ownership: 28.41% → 30.06% (+1.6%)

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

Holders
39
Holders Change
+7
Holders Change %
+21.88%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$6.82M
2
BlackRock
BlackRock
New York
+$6.09M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.81M
4
BI
BVF Inc
California
+$2.01M
5
Citadel Advisors
Citadel Advisors
Florida
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
PC
PointState Capital
New York
-$4.51M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.13M
3
SFM
Sphera Funds Management
Israel
-$1.82M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$844K
5
BAM
Belpointe Asset Management
Nevada
-$400K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$53M +$3.81M +403,086 +8%
Temasek Holdings
2
Temasek Holdings
Singapore
$24.7M – – –
DFO
3
Duquesne Family Office
New York
$23.5M – – –
BI
4
BVF Inc
California
$21.1M +$2.01M +212,527 +11%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$14.9M -$844K -89,363 -5%
O
6
OrbiMed
New York
$13.6M – – –
AG
7
Artal Group
Luxembourg
$7.09M – – –
Marshall Wace
8
Marshall Wace
United Kingdom
$6.95M +$6.82M +722,511 +5,395%
BlackRock
9
BlackRock
New York
$6.09M +$6.09M +644,675 New
Citadel Advisors
10
Citadel Advisors
Florida
$4.25M +$1.56M +164,701 +58%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$3.58M -$6.61K -700 -0.2%
SFM
12
Sphera Funds Management
Israel
$2.94M -$1.82M -192,950 -38%
TCM
13
Tekla Capital Management
Massachusetts
$1.62M – – –
AA
14
ALPS Advisors
Colorado
$1.47M +$1.47M +155,678 New
Balyasny Asset Management
15
Balyasny Asset Management
Illinois
$1.04M -$4.13M -437,054 -80%
State of New Jersey Common Pension Fund D
16
State of New Jersey Common Pension Fund D
New Jersey
$739K – – –
Renaissance Technologies
17
Renaissance Technologies
New York
$661K +$166K +17,600 +34%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$493K -$11.9K -1,261 -2%
TI
19
Trexquant Investment
Connecticut
$468K +$468K +49,544 New
EIM
20
Essex Investment Management
Massachusetts
$359K +$359K +37,968 New
State Street
21
State Street
Massachusetts
$316K +$20K +2,118 +7%
Morgan Stanley
22
Morgan Stanley
New York
$267K -$23.8K -2,517 -8%
Goldman Sachs
23
Goldman Sachs
New York
$257K +$257K +27,191 New
CLOS
24
Compagnie Lombard Odier SCmA
Switzerland
$236K -$82.1K -8,700 -26%
BFM
25
Boothbay Fund Management
New York
$230K -$147K -15,618 -39%
1
2

ACIU Hedge Fund Activity: Q4 2018 in Review

39 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2018, worth a combined $191M — up 25% from $153M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ACIU positions and 8 closed out — a net gain of 7 holders — while 7 added to existing stakes and 10 trimmed.

The largest buyer was Marshall Wace, adding an estimated $6.82M. The largest seller was PointState Capital, exiting entirely with an estimated $4.51M sold.

  • 39 institutional investors held AC Immune (ACIU) as of Q4 2018, up from 32 in Q3 2018.
  • Funds reported $191M of AC Immune stock for Q4 2018, up 25% quarter-over-quarter.
  • 15 funds opened new AC Immune positions in Q4 2018 and 8 closed out, a net change of +7 holders.
  • The largest AC Immune buyer in Q4 2018 was Marshall Wace, an estimated $6.82M added.
  • The largest AC Immune seller in Q4 2018 was PointState Capital, an estimated $4.51M sold.

Based on aggregated 13F filings for Q4 2018.